Survival impact of tamoxifen use for breast cancer risk reduction: projections from a patient-specific Markov model
Authors
Col, Nananda F.Goldberg, Robert J.
Orr, Richard K.
Erban, John K.
Fortin, Jennifer M.
Chlebowski, Rowan T.
UMass Chan Affiliations
Department of Medicine, Division of Cardiovascular MedicineDocument Type
Journal ArticlePublication Date
2002-10-09Keywords
Anticarcinogenic AgentsBreast Neoplasms
Cohort Studies
*Decision Support Techniques
Endometrial Neoplasms
Female
Humans
Hysterectomy
*Life Expectancy
*Markov Chains
Middle Aged
Patient Selection
*Postmenopause
Predictive Value of Tests
Risk Assessment
Risk Factors
*Survival Analysis
Tamoxifen
Thromboembolism
Time Factors
Bioinformatics
Biostatistics
Epidemiology
Health Services Research